Skip to main content

Search

Study Title Study Sponsor Status Study Drug Trial Phase Study Protocol Number Site
Open Label, Multinational, Multicenter, Real World Treatment Study of Single Agent AZD9291 for Patients with Advanced/Metastatic Epidermal Growth Factor Receptor (EGFR)T790M Mutation-Positive Non-Small Cell Lung Cancer (NSCLC) Who Have Received Prior Therapy with an EGFR Tyrosine Kinase Inhibitor(EGFR-TKI) AstraZeneca Completed Osimertinib (AZD9291) 3 D5160C00022 KFSH
Multicentre, Randomised, Controlled, Open-label Study Comparing the Efficacy and Safety of Slow Repeated IV Infusions of 2 Doses of Doxorubicin Transdrug™ (DT) (20mg/m2 and 30mg/m2) to Those of Best Standard of Care (BSC) in Patients With Advanced Hepatocellular Carcinoma (HCC) After Failure or Intolerance to Sorafenib. ReLive Study. Onxeo Completed Doxorubicin 3 BA2011/03/04 KAUH-J
Multi-Center Open Label Study to Evaluate the Safety, Tolerability and Efficacy of Tocilizumab in Patients With Active Rheumatoid Arthritis on Background Non-biologic DMARDs Who Have An Inadequate Response to Current Non-Biologic DMARD or Anti-TNF Therapy Roche Completed Tocilzumab 3b MA21573 KFSH & RC-J
Multicenter Inetrnational neoadjuvant randomized double-blind trial comparing fulvestrant to a combination of fulvestrant and palcociclib in patients with operable luminal breast cancer responding to fulvestrant ICR Group - International Cancer Research group Ongoing palbociclib fulvestrant 3 ICRG 1201 KKUH
"Long-term Safety and Efficacy Study of Ferriprox® for the Treatment of Transfusional Iron Overload in Patients with Sickle Cell Disease or Other Anemias" ApoPharma Ongoing Deferiprone 3b LA38-EXT ACH
Lessening Organ Dysfunction with VITamin C KAIMRC Completed ascorbic acid injection 3 CT19/022/R King Abdulaziz Medical City NG (Riyadh)
Ketamine for Acute Painful Crisis in Sickle Cell Disease Patients: Prospective Randomized Control trial King Fahad Hospital of the University Completed Ketamine 3 2016-01-042 -Version 02 KFUH
Intra Peritoneal Instillation of Ropivacaine with or without Dexmedetomidine for Postoperative Analgesia After Laparoscopic Sleeve Gastrectomy. A randomized controlled King Abdullah Medical City, Makkah Completed Dexmedetomidine 2 version 4 KAMC
Intra Peritoneal Instillation of Ropivacaine with or without Dexmedetomidine for Postoperative Analgesia After Laparoscopic Sleeve Gastrectomy. A randomized controlled King Abdullah Medical City, Makkah Completed Dexmedetomidine 2 version 4 KAMC
International, randomized, open label study to compare the safety and efficacy of lixisenatide vs sulfonylurea on top of basal insulin treatment in Type 2 Diabetes Mellitus subjects who elect to fast during Ramadan Sanofi Terminated Lixisenatide 3 LPS14410 KKUH
View 311 - 320 From 828